GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunogen Inc (FRA:IMU) » Definitions » Price-to-Funds-From-Operations

Immunogen (FRA:IMU) Price-to-Funds-From-Operations : (As of May. 05, 2024)


View and export this data going back to . Start your Free Trial

What is Immunogen Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Immunogen (FRA:IMU) Business Description

Industry
Traded in Other Exchanges
Address
830 Winter Street, Waltham, MA, USA, 02451
Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.